Informazioni
Non ci sono recensioni
Definition of IPF
Pages 3-9
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Idiopathic Pulmonary Fibrosis
Advances in Diagnostic Tools and Disease Management
Nakamura, Aoshiba
Editore
Springer
Anno
2016
Pagine
259
ISBN
9784431555810
120,00 €
From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.
-
-
Epidemiology and Risk Factors of IPF
Pages 11-25
-
Acute Exacerbation of IPF
Pages 27-42
-
Pathogenesis of IPF
Pages 43-58
-
Specific Serum Markers of IPF
Pages 61-76
-
High-Resolution Computed Tomography of Honeycombing and IPF/UIP
Pages 77-104
-
Pathology of IPF
Pages 105-132
-
Differential Diagnosis of IPF
Pages 133-144
-
Pharmacotherapy of IPF Using Antifibrotic Compounds
Pages 147-159
-
Pharmacotherapy of IPF (Corticosteroids, Immunosuppressants, Etc.)
Pages 161-170
-
Non-pharmacological Therapy for IPF
Pages 171-188
-
Pharmacotherapy of Acute Exacerbation of IPF (Corticosteroids, Immunosuppressants, and Direct Hemoperfusion with Polymyxin)
Pages 189-201
-
Combined Pulmonary Fibrosis and Emphysema (CPFE)
Pages 205-215
-
Common Pathways in IPF and Lung Cancer
Pages 217-247
-
Acute Exacerbation of Interstitial Pneumonia After Pulmonary Resection for Lung Cancer
Pages 249-259
